Terumo Reports Higher Q3 Earnings, Raises FY26 Guidance

Terumo (TYO:9733) reported higher earnings for the nine months ended December 31, 2025, with net revenue up 10.2% to ¥29.65 billion and operating profit rising 6.3% to ¥1.04 billion. The company raised its full-year 2026 guidance, citing stronger demand in Asia-Pacific and North America, particularly in vascular access products. Management attributed the improvement to higher-than-expected pricing and cost optimization. The stock closed 1.8% higher on the Tokyo exchange on February 13, 2026.